Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers

References

• Anderson KS, LaBaer J. (2005). The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 4:1123–1133.
   PubMed Web of Science ®Google Scholar
• Anderson KS, Ramachandran N, Wong J, Raphael JV, Hainsworth E, Demirkan G, Cramer D, Aronzon D, Hodi FS, Harris L, Logvinenko T, LaBaer J. (2008). Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 7:1490–1499.
   PubMed Web of Science ®Google Scholar
• Bankovic J, Stojsic J, Jovanovic D, Andjelkovic T, Milinkovic V, Ruzdijic S, Tanic N. (2010). Identification of genes associated with non-small-cell lung cancer promotion and progression. Lung Cancer 67:151–159.
   Google Scholar
• Bau DT, Yang MD, Tsou YA, Lin SS, Wu CN, Hsieh HH, Wang RF, Tsai CW, Chang WS, Hsieh HM, Sun SS, Tsai RY. (2010). Colorectal cancer and genetic polymorphism of DNA double-strand break repair gene XRCC4 in Taiwan. Anticancer Res 30:2727–2730.
   PubMed Web of Science ®Google Scholar
• Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, Maddison P, Healey G, Fairley GH, Barnes AC, Robertson JF. (2011). Clinical validation of an autoantibody test for lung cancer. Ann Oncol 22:383–389.
   PubMed Web of Science ®Google Scholar
• Behrends U, Schneider I, Rössler S, Frauenknecht H, Golbeck A, Lechner B, Eigenstetter G, Zobywalski C, Müller-Weihrich S, Graubner U, Schmid I, Sackerer D, Späth M, Goetz C, Prantl F, Asmuss HP, Bise K, Mautner J. (2003). Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. Int J Cancer 106:244–251.
   PubMedGoogle Scholar
• Caron M, Choquet-Kastylevsky G, Joubert-Caron R. (2007). Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 6:1115–1122.
   PubMed Web of Science ®Google Scholar
• Casiano CA, Mediavilla-Varela M, Tan EM. (2006). Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics 5:1745–1759.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159.
   PubMed Web of Science ®Google Scholar
• Comtesse N, Zippel A, Walle S, Monz D, Backes C, Fischer U, Mayer J, Ludwig N, Hildebrandt A, Keller A, Steudel WI, Lenhof HP, Meese E. (2005). Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci USA 102:9601–9606.
   PubMed Web of Science ®Google Scholar
• Desmetz C, Bascoul-Mollevi C, Rochaix P, Lamy PJ, Kramar A, Rouanet P, Maudelonde T, Mangé A, Solassol J. (2009a). Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. Clin Cancer Res 15:4733–4741.
   PubMed Web of Science ®Google Scholar
• Desmetz C, Cortijo C, Mangé A, Solassol J. (2009b). Humoral response to cancer as a tool for biomarker discovery. J Proteomics 72:982–988.
   Google Scholar
• Desmetz C, Maudelonde T, Mangé A, Solassol J. (2009c). Identifying autoantibody signatures in cancer: a promising challenge. Expert Rev Proteomics 6:377–386.
   PubMed Web of Science ®Google Scholar
• Devitt G, Meyer C, Wiedemann N, Eichmüller S, Kopp-Schneider A, Haferkamp A, Hautmann R, Zöller M. (2006). Serological analysis of human renal cell carcinoma. Int J Cancer 118:2210–2219.
   Google Scholar
• Ehrlich JR, Qin S, Liu BC. (2006). The ‘reverse capture’ autoantibody microarray: a native antigen-based platform for autoantibody profiling. Nat Protoc 1:452–460.
   PubMed Web of Science ®Google Scholar
• Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, Chaudhuri J, Horner J, DePinho RA, Alt FW. (2000). Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404:897–900.
   PubMed Web of Science ®Google Scholar
• Garifulin OM, Kykot VO, Gridina NY, Kijamova RG, Gout IT,Filonenko VV. (2003). SEREX-analysis of three colon cancer cases. Exp Oncol 25:128–131.
   Google Scholar
• Greiner J, Ringhoffer M, Taniguchi M, Hauser T, Schmitt A, Döhner H, Schmitt M. (2003). Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. Int J Cancer 106:224–231.
   PubMed Web of Science ®Google Scholar
• Gnjatic S, Ritter E, Büchler MW, Giese NA, Brors B, Frei C, Murray A, Halama N, Zörnig I, Chen YT, Andrews C, Ritter G, Old LJ, Odunsi K, Jäger D. (2010). Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci USA 107:5088–5093.
   PubMed Web of Science ®Google Scholar
• Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA. (2010). Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 391:937–945.
   PubMed Web of Science ®Google Scholar
• Gunawardana CG, Diamandis EP. (2007). High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett 249:110–119.
   PubMed Web of Science ®Google Scholar
• Hardouin J, Lasserre JP, Sylvius L, Joubert-Caron R, Caron M. (2007). Cancer immunomics: from serological proteome analysis to multiple affinity protein profiling. Ann N Y Acad Sci 1107:223–230.
   PubMed Web of Science ®Google Scholar
• Heisel SM, Ketter R, Keller A, Klein V, Pallasch CP, Lenhof HP, Meese E. (2008). Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation. PLoS ONE 3:e2164.
   Google Scholar
• Ikematsu N, Yoshida Y, Kawamura-Tsuzuku J, Ohsugi M, Onda M, Hirai M, Fujimoto J, Yamamoto T. (1999). Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18:7432–7441.
   PubMed Web of Science ®Google Scholar
• Kyyamova RG, Rodnin NV, Garifulin OM, Tykhonkova IA, Koroleva EP, Malets MS, Gout IT, Filonenko VV (2004) Allogeneic screening of tumor antigens from thyroid cancer cDNA libraries. Biopolym Cell20:151–157
   Google Scholar
• Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ, Scanlan MJ. (2003). Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA 100:2651–2656.
   PubMed Web of Science ®Google Scholar
• Li L, Wang K, Dai L, Wang P, Peng XX, Zhang JY. (2008). Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer. Mol Med Report 1:589–594.
   PubMed Web of Science ®Google Scholar
• Ludwig N, Keller A, Heisel S, Leidinger P, Klein V, Rheinheimer S, Andres CU, Stephan B, Steudel WI, Graf NM, Burgeth B, Weickert J, Lenhof HP, Meese E. (2009). Improving seroreactivity-based detection of glioma. Neoplasia 11:1383–1389.
   Google Scholar
• Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y, Onda M, Yoshida Y, Nishiyama A, Yamamoto T. (1996). Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene 12:705–713.
   PubMed Web of Science ®Google Scholar
• Nolen B, Winans M, Marrangoni A, Lokshin A. (2009). Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay. J Immunol Methods 344:116–120.
   Google Scholar
• Pallasch CP, Struss AK, Munnia A, König J, Steudel WI, Fischer U, Meese E. (2005). Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival. Int J Cancer 117:456–459.
   PubMed Web of Science ®Google Scholar
• Qin S, Qiu W, Ehrlich JR, Ferdinand AS, Richie JP, O’leary MP, Lee ML, Liu BC. (2006). Development of a “reverse captureâ autoantibody microarray for studies of antigen-autoantibody profiling. Proteomics 6:3199–3209.
   PubMed Web of Science ®Google Scholar
• Ramachandran N, Hainsworth E, Bhullar B, Eisenstein S, Rosen B, Lau AY, Walter JC, LaBaer J. (2004). Self-assembling protein microarrays. Science 305:86–90.
   PubMed Web of Science ®Google Scholar
• Rodnin NV, Tykhonkova IO, Nemazany IO, Gorlova LM, Komissarenko IV, Palchevskiy SS, Kuharenko OP, Drobot LB, Matsuka GH, Filonenko VV, Gout IT. (2000). Serological identification of autoimmune reactive antigens in human thyroid cancer cells. Exp Oncol 22:135–138.
   Google Scholar
• Rodnin NV, Tykhonkova IO, Kyyamova RG, Garifulin OM, Gout IT, Filonenko VV. (2003). Identification of tumor-associated antigens in human thyroid papillar carcinoma. Biopolym Cell 19:541–547.
   Google Scholar
• Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci O, Sahin U, Pfreundschuh M, Old LJ. (1998). Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76:652–658.
   PubMed Web of Science ®Google Scholar
• Scanlan MJ, Welt S, Gordon CM, Chen YT, Gure AO, Stockert E, Jungbluth AA, Ritter G, Jäger D, Jäger E, Knuth A, Old LJ. (2002). Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 62:4041–4047.
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, Glickman JN, Chirieac LR, Hartman ML, Taillon BE, Du L, Bouffard P, Kingsmore SF, Miller NA, Farmer AD, Jensen RV, Gullans SR, Bueno R. (2008). Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci USA 105:3521–3526.
   Google Scholar
• Tan EM. (2001). Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 108:1411–1415.
   PubMed Web of Science ®Google Scholar
• Tan HT, Low J, Lim SG, Chung MC. (2009). Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276:6880–6904.
   PubMed Web of Science ®Google Scholar
• Taniwaki M, Daigo Y, Ishikawa N, Takano A, Tsunoda T, Yasui W, Inai K, Kohno N, Nakamura Y. (2006). Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol 29:567–575.
   Google Scholar
• de Visser KE, Eichten A, Coussens LM. (2006). Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24–37.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM. (2005). Autoantibody signatures in prostate cancer. N Engl J Med 353:1224–1235.
   PubMed Web of Science ®Google Scholar
• Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF. (2002). Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 169:1102–1109.
   PubMed Web of Science ®Google Scholar
• Yamada K, Senju S, Nakatsura T, Murata Y, Ishihara M, Nakamura S, Ohno S, Negi A, Nishimura Y. (2001). Identification of a novel autoantigen UACA in patients with panuveitis. Biochem Biophys Res Commun 280:1169–1176.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM. (2003). Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev 12:136–143.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK. (2007). Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol 46:107–114.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Pang ST, Kasper KA, Luan C, Wondergem B, Lin F, Chuang CK, Teh BT, Yang XJ. (2011). FXYD3: A Promising Biomarker for Urothelial Carcinoma. Biomark Insights 6:17–26.
   Google Scholar